Satyavrat Shukla
2022
In 2022, Satyavrat Shukla earned a total compensation of $1.7M as President and Chief Executive Officer and Former Chief Financial Officer and Treasurer at Spero Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Bonus | $168,000 |
|---|---|
| Non-Equity Incentive Plan | $172,800 |
| Option Awards | $424,807 |
| Salary | $478,333 |
| Stock Awards | $424,997 |
| Other | $4,133 |
| Total | $1,673,070 |
Shukla received $478.3K in salary, accounting for 29% of the total pay in 2022.
Shukla also received $168K in bonus, $172.8K in non-equity incentive plan, $424.8K in option awards, $425K in stock awards and $4.1K in other compensation.
Rankings
In 2022, Satyavrat Shukla's compensation ranked 2,035th out of 5,736 executives tracked by ExecPay. In other words, Shukla earned more than 64.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,035 out of 5,736 | 65th |
Division Manufacturing | 1,094 out of 3,125 | 65th |
Major group Chemicals And Allied Products | 470 out of 1,416 | 67th |
Industry group Drugs | 431 out of 1,317 | 67th |
Industry Pharmaceutical Preparations | 314 out of 963 | 67th |
Source: SEC filing on September 1, 2023.
Shukla's colleagues
We found two more compensation records of executives who worked with Satyavrat Shukla at Spero Therapeutics in 2022.